Abstract:Eptapirone free base, F11440,4-methyl-2-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-1,2,4-triazine-3,5(2H,4H)-dione, represents a potent and selective 5-HT1A receptor agonist with high efficacy and the potential to regulate anxiety disorders. Herein, we report a method to retro-synthesize eptapirone free base. The compound consists of heterocyclic aromatic portion and aliphatic portion, and the synthetic route consisted of a total of nine steps with an overall yield of 8.8% starting from the commercially available materials. The key steps in the synthetic method involved: (1) using sodium hydroxide and ethylene glycol as solvent resulted in a better cyclization and yield (61.6%) of 1,2,4-triazine-3,5(2H,4H)-dione; (2) an acceptable yield (63.1%) of 4-tert-butyl(pyrimidin-2-yl)piperazine-1-carboxylate was obtained under an optimized conditions of using triethylamine as a base, ethanol as a solvent, and a reaction temperature of 50 °C for 16 h with non-metal catalysis and less byproducts; (3) the reaction step of eptapirone could get a better yield (49.6%) with an optimized condition of potassium carbonate as a base, acetonitrile as a solvent, NaI as a catalyst, and a reaction temperature of 50 °C for 12 h by nucleophilic substitution reaction. The main advantages of this route were an acceptable product purity, the commercial availability of all starting materials and the absence of high temperature, high pressure and noble metal catalysts, which could result in more feasible commercial applications.

Improved synthesis of fibroblast growth factor receptor inhibitor AZD4547

Improved Synthetic Approach to Tenatoprazole

Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives

An improved synthetic strategy for the multigram-scale synthesis of DNA–PK inhibitor AZD7648

Convenient Synthesis and Characterization of Novel 4-[2-ethoxy-5-(4-methyl-1-piperazinesulphonyl)benzamido]-3-isobutyl-1-methyl-1h-pyrazole-5-carboxamide: Key Precursor for Isobutyl Sildenafil

Improved Synthesis of (R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c] Pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide

Design and Synthesis of 5-Aminopyrazole and 5-Aminotriazole Derivatives As Fibroblast Growth Factor Receptor Inhibitors

Improved Synthesis of Gefitinib

A Concise Enantioselective Synthesis of Fluorinated Pyrazolo-Piperidine GSK3901383A Enabled by an Organocatalytic Aza-Michael Addition

Improved Synthetic Method of Anticancer Drug Anastrozole

An Improved Synthesis of the 5-HT1A Receptor Agonist Eptapirone Free Base

Improved synthesis of 5-hydroxy-5H-[1]benzopyrano[2,3-b]pyridine

An Improved Synthetic Process for Gefitinib

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors

Improved Synthesis of Ambrisentan

Synthesis of N-(3-chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl) oxy) quinazolin-4-amine

Improved Synthesis of 1H,4H-3,6-dinitropyrazolo[4,3-C] pyrazole

Pharmacokinetics-Driven Optimization of 7-Methylimidazo[1,5-a]pyrazin-8(7h)-one As Novel BRD4 Inhibitors.

Improved Synthesis of Pazufloxacin Mesylate

Synthesis and antitumor activity of ethyl 5-methyl-4-[ 3-chloro-4-(3-fluoro-benzyloxy)-phenylamino]-pyrrolo-triazine-6-carboxylate

Improved Synthesis of 4-[4-(5-oxo-1,5-dihydro-[1,2,4]triazoyl-4-yl) Phenyl]piperazine-1-carboxylic T-Butyl Ester